Infectious complications in non-myeloablative conditioning and allogeneic peripheral blood stem cell transplantation for patients with multiple myeloma.

被引：0
|
作者：
Lee, CK
Dignani, C
Barlogie, B
Guido, T
Morris, CL
Badros, AZ
Cottler-Fox, MH
van Rhee, F
Zanagari, M
Fassas, A
Anaissie, EJ
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Hosp Clin Sao Paulo, Sao Paulo, Brazil
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Loma Linda Univ, Med Ctr, Loma Linda, CA 92350 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2471
引用
收藏
页码：627A / 627A
页数：1
相关论文
共 50 条
  • [31] Red blood cell and reticulocyte chimerism studies in non-myeloablative allogeneic peripheral blood haematopoietic stem cell transplantation
    Harritshoj, L
    Berkowicz, A
    Petersen, SL
    Madsen, HO
    Ryder, LP
    Vindelov, L
    Andersen, P
    Dickmeiss, E
    BONE MARROW TRANSPLANTATION, 2004, 33 : S116 - S117
  • [32] Quantitative analysis of chimerism after allogeneic stem cell transplantation with non-myeloablative conditioning in paediatric patients
    Di Martino, D.
    Terranova, M. P.
    Di Duca, M.
    Faraci, M.
    Dallorso, S.
    Miano, M.
    Dini, G.
    Morreale, G.
    Lanino, E.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S302 - S303
  • [33] Infectious morbidity after non-myeloablative allogeneic hemapoietic stem cell transplantation (AHSCT)
    Thiébaut, A
    Antal, D
    Bilger, K
    Michallet, A
    Audigier, C
    Nicolini, F
    Michallet, M
    BONE MARROW TRANSPLANTATION, 2002, 29 : S148 - S148
  • [34] Non-myeloablative and myeloablative peripheral blood stem cell transplantation: Comparison of post-transplant complications and survival.
    Tzolas, AC
    Devidas, M
    Mina, S
    Cartwright, B
    Salansky, J
    Finiewicz, K
    Moreb, J
    Khan, S
    Wingard, JR
    Reddy, V
    BLOOD, 2001, 98 (11) : 403A - 403A
  • [35] Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
    Campbell, P.
    Walker, P.
    Avery, S.
    Patil, S.
    Curtis, D.
    Schwarer, A.
    Wei, A.
    Kalff, A.
    Muirhead, J.
    Spencer, A.
    BLOOD CANCER JOURNAL, 2014, 4 : e213 - e213
  • [36] Non-myeloablative conditioning regimen in Allogeneic Peripheral Blood Stem Cell Transplantation (AlloPBSCT) for high-risk Hematologic Malignancies (HM)
    Vaz, CP
    Campilho, F
    Campos, A
    Carvalhais, A
    Roncon, S
    Martinho, A
    Duarte, R
    Raimundo, A
    Avila, A
    Pimentel, P
    BONE MARROW TRANSPLANTATION, 2001, 27 : S293 - S293
  • [37] Allogenic stem cell transplantation after non-myeloablative conditioning regimen ("mini-allogeneic" stem cell transplantation)
    Milpied, N
    PATHOLOGIE BIOLOGIE, 2002, 50 (01): : 42 - 44
  • [38] Non-myeloablative stem cell transplantation - High stem cell dose will not compensate for T cell depletion in allogeneic non-myeloablative stem cell transplantation
    Passweg, JR
    Meyer-Monard, S
    Gregor, M
    Favre, G
    Heim, D
    Ebnoether, M
    Tichelli, A
    Gratwohl, A
    BONE MARROW TRANSPLANTATION, 2002, 30 (05) : 267 - 271
  • [39] Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
    de Donk, N. W. C. J. van
    Kroeger, N.
    Hegenbart, U.
    Corradini, P.
    Miguel, J. F. San
    Goldschmidt, H.
    Perez-Simon, J. A.
    Zijlmans, M.
    Raymakers, R. A.
    Montefusco, V.
    Ayuk, F. A.
    van Oers, M. H. J.
    Nagler, A.
    Verdonck, L. F.
    Lokhorst, H. M.
    BONE MARROW TRANSPLANTATION, 2006, 37 (12) : 1135 - 1141
  • [40] Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
    N W C J van de Donk
    N Kröger
    U Hegenbart
    P Corradini
    J F San Miguel
    H Goldschmidt
    J A Perez-Simon
    M Zijlmans
    R A Raymakers
    V Montefusco
    F A Ayuk
    M H J van Oers
    A Nagler
    L F Verdonck
    H M Lokhorst
    Bone Marrow Transplantation, 2006, 37 : 1135 - 1141
12345